How real-world data is powering rare disease research

As real-world data (RWD) transforms the drug development landscape, its power to advance research is becoming tangible in the most challenging therapeutic arena—rare diseases. In this series, Parexel experts discuss current initiatives in North America, Europe and China that are accelerating the use of RWD in rare disease research.
 

Download the whitepaper for North America

Download the whitepaper for Europe

Download the whitepaper for China